Modalis Therapeutics Corporation (JP:4883) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Modalis Therapeutics Corporation has reported a non-operating income of 19 million yen due to favorable foreign exchange rate fluctuations for the first nine months of 2024. This reflects positively on the company’s financial performance, showcasing effective management of foreign currency assets and liabilities.
For further insights into JP:4883 stock, check out TipRanks’ Stock Analysis page.